Anna Ermakova
Research Scientist at Beckley Psytech and psychedelic research contributor
Key Impact
She is an author on multiple influential 5-MeO-DMT clinical and review papers, helping build the evidence base for psychedelic therapies in depression and alcohol use disorder.
Background & Research
Anna O. Ermakova is also referred to publicly as Anya Ermakova. Public profiles and articles describe her as a research scientist working with Beckley Psytech, with interests spanning nature conservation, ethnobotany, neuroscience, and psychiatry. She has contributed to 5-MeO-DMT research across review, phenomenology, and clinical-trial publications.
Collaboration Network
6 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Safety & Risk ManagementHealthy VolunteersMedicinal Chemistry & Drug DevelopmentChronic PainSubstance Use Disorders (SUD)Depressive DisordersAlcohol Use Disorder (AUD)Public Health, Prevention & Behaviour ChangeOlder AdultsMajor Depressive Disorder (MDD)Treatment-Resistant Depression (TRD)Headache Disorders (Cluster & Migraine)Palliative & End-of-Life DistressPersonality & Trait FactorsAnxiety Disorders